1. Home
  2. SBS vs NBIX Comparison

SBS vs NBIX Comparison

Compare SBS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia de saneamento Basico

SBS

Companhia de saneamento Basico

HOLD

Current Price

$4.61

Market Cap

18.7B

Sector

Utilities

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$152.57

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBS
NBIX
Founded
1954
1992
Country
Brazil
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
15.5B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
SBS
NBIX
Price
$4.61
$152.57
Analyst Decision
Strong Buy
Analyst Count
0
22
Target Price
N/A
$180.91
AVG Volume (30 Days)
8.7M
1.4M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
41.95
EPS
N/A
3.30
Revenue
N/A
$161,626,000.00
Revenue This Year
N/A
$24.73
Revenue Next Year
$16.85
$13.14
P/E Ratio
$15.19
$46.34
Revenue Growth
N/A
977.51
52 Week Low
$4.45
$122.14
52 Week High
$35.79
$186.12

Technical Indicators

Market Signals
Indicator
SBS
NBIX
Relative Strength Index (RSI) 27.14 37.25
Support Level N/A $152.67
Resistance Level $5.66 $161.29
Average True Range (ATR) 0.15 4.10
MACD -0.02 -1.08
Stochastic Oscillator 12.18 21.47

Price Performance

Historical Comparison
SBS
NBIX

About SBS Companhia de saneamento Basico

Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in Sao Paulo State, and supplies treated water and sewage services on a wholesale basis. SABESP may perform activities in other states and countries and can operate in drainage, urban cleaning, solid waste handling, and energy markets. The company determined that it has a single operating segment, which is the provision of sanitation services.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: